Palatin Announces Preliminary Q4 Vyleesi Results: Net Product Revenue Up 122% YoY To $1.7M
Portfolio Pulse from Benzinga Newsdesk
Palatin Technologies, Inc. (NYSE:PTN) announced preliminary Q4 results for its Vyleesi product, showing a 122% YoY increase in net product revenue to $1.7M. Gross product revenue was $4.1M, a 78% increase over the same quarter in 2022. Prescriptions dispensed also increased by 89% over the comparable quarter in 2022.
July 11, 2023 | 11:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Palatin's Q4 results show strong growth in revenue and prescriptions for its Vyleesi product, which could positively impact its stock price.
The significant YoY increase in both gross and net product revenue for Vyleesi, as well as the increase in prescriptions dispensed, indicates strong demand and successful commercialization of the product. This could lead to increased investor confidence and a potential rise in Palatin's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100